Business, ICT  

United BioSource targets elearning for medical technology sector

Bethesda, Md., USA. United BioSource Corporation (UBC) has acquired iLearn, an advanced learning management system developed by Warrington, UK-based IQ Consultancy. The robust web-based technology allows UBC to offer new enterprise learning services to pharmaceutical and biotechnology clients. The acquisition is part of the UBC strategy of building integrated capabilities to meet growing demand by the pharmaceutical, biotechnology, medical device and diagnostics sectors for evidence-based product development and commercialization services.

The iLearn technology, to be renamed the "UBC Learning Zone", operates from a secure, validated web-based platform and will enable UBC to deliver effective, user friendly, training programs that can be accessed at any time from any location with an Internet connection. It can deliver didactic training presentations, instructor-led sessions, and supporting materials and documentation. UBC clients can use the UBC Learning Zone for a broad array of training and education needs, including investigator training, medical education for health care professionals, and a broad array of patient-based education, including disease management, drug compliance and patient retention programs. International training and education projects have been successfully implemented at several leading pharmaceutical companies.

"The UBC Learning Zone is an important addition to UBC's rapidly-growing portfolio of technologies," said Catherine Spear, Group President of UBC's Training and Education Group. "This robust, secure and reliable system will help us build and deploy customized training programs that meet our clients' global needs. Because this technology was designed specifically for heavily regulated industries, it offers all of the essential compliance, reporting and regulatory tools necessary in the pharmaceutical, biotechnology and medical device industries."

The acquisition is the latest in a series of strategic moves announced since UBC raised $153 million in equity capital from a syndicate of leading private equity firms. Other recent acquisitions include MetaWorks Inc, a leading provider of systematic reviews and meta-analyses to inform development, marketing, and regulatory decision-making regarding health care products and services.

To top

To top